Johannesburg Declaration, A civil society declaration to UN Secretary- General High Level Panel on Access to Medicines highlights the factors that interlink system of financing biodmedical research, innovation and access to health technologies. It denounces the research funding that relies upon the grant of monopolies which eventually ‘produces to innovation gaps, inefficiencies, and distortions in the development of new health technologies’. The declaration clearly recommends ‘the costs of medical research and development should be delinked from the price of health technologies.’
- HIV+ community stage protest to drop harmful provisions in RCEP; arrested & released
- Trading away health
- Regional Comprehensive Economic Partnership: Boosting trade or extending monopolies for big pharma?
- Hyderabad: NGOs hold protest against RCEP talks
- A Trade Deal Could Hit Affordable & Generic Medicines in India. Here’s What You Need to Know.